Showing results (221-230 of 235) with videos related to
Sort By:
Pageof 24
Gastroenterology|November 1, 1978
Early idiopathic hemochromatosis with absent stainable bone marrow iron storesB L Blitzer, G B Weiss, G W Osbaldiston, et al.The New England Journal of Medicine|June 9, 1988
Detection of circulating tumor necrosis factor after endotoxin administrationH R Michie, K R Manogue, D R Spriggs, et al.The Journal of Experimental Medicine|October 1, 1992
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxinJ P Cobb, C Natanson, W D Hoffman, et al.JAMA|May 5, 1993
A controlled trial of HA-1A in a canine model of gram-negative septic shockZ M Quezado, C Natanson, D W Alling, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shockZ M Quezado, C Natanson, S M Banks, et al.The Journal of Experimental Medicine|June 1, 1986
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1C A Dinarello, J G Cannon, S M Wolff, et al.The American Journal of Physiology|November 1, 1990
Antibiotics versus cardiovascular support in a canine model of human septic shockC Natanson, R L Danner, J M Reilly, et al.Cytokine|September 1, 1992
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansE V Granowitz, R Porat, J W Mier, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humansE V Granowitz, R Porat, J W Mier, et al.Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1993
Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemiaA A Santos, M R Scheltinga, E Lynch, et al.Pageof 24